Jassim Al Suwaidi

ORCID: 0000-0002-5299-9106
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrest and Resuscitation
  • Cardiac Health and Mental Health
  • Blood Pressure and Hypertension Studies
  • Cardiac Valve Diseases and Treatments
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes Treatment and Management
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Disease and Adiposity
  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Health and Risk Factors
  • Cardiac Structural Anomalies and Repair
  • Cardiac Arrhythmias and Treatments
  • Health Promotion and Cardiovascular Prevention
  • Dietary Effects on Health
  • Venous Thromboembolism Diagnosis and Management
  • Mechanical Circulatory Support Devices
  • Cardiac pacing and defibrillation studies

Hamad Medical Corporation
2016-2025

National Center for Cancer Care and Research
2025

Weill Cornell Medical College in Qatar
2012-2024

King Saud University
2012-2022

Hamad General Hospital
2012-2022

Qatar Cardiovascular Research Center
2012-2022

Qatar Airways (Qatar)
2005-2022

National Guard Health Affairs
2022

King Abdulaziz Medical City
2022

Sana'a University
2011-2022

Background —Coronary endothelial dysfunction is characterized by vasoconstrictive response to the endothelium-dependent vasodilator acetylcholine. Although considered an early phase of coronary atherosclerosis, there a paucity information regarding outcome these patients. Thus, this study was designed evaluate patients with mild artery disease on basis their function. Methods and Results —Follow-up obtained in 157 mildly diseased arteries who had undergone vascular reactivity evaluation...

10.1161/01.cir.101.9.948 article EN Circulation 2000-03-07

Background— Outcomes in patients with mild to moderate renal function (RF) abnormalities presenting acute coronary syndromes (ACS) are not well defined. Methods and Results— A convenience sample of 4 ACS trial databases including all enrolled was assessed determine 30- 180-day outcomes. The trials were Global Use Strategies Open Occluded Coronary Arteries (GUSTO) IIb, GUSTO-III, Platelet Glycoprotein IIb/IIIa Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT),...

10.1161/01.cir.0000027560.41358.b3 article EN Circulation 2002-08-20

Aims We assessed the effect of fasting during Ramadan on blood pressure (BP), body weight, plasma lipid, and lipoprotein variables among healthy normal individuals. Methods 102 (68% male) multi-ethnic volunteers; mean age ± SD (38.7±10.5 years) were randomly recruited in Al-Ain, United Arab Emirates (UAE), to be investigated before Ramadan, one day after end four weeks Ramadan. Anthropometric, demographic, total cholesterol (TC), triglyceride (TG), high density lipoprotein–cholesterol...

10.1371/journal.pone.0047615 article EN cc-by PLoS ONE 2012-10-24

Abstract COVID-19 complications still present a huge burden on healthcare systems and warrant predictive risk models to triage patients inform early intervention. Here, we profile 893 plasma proteins from 50 severe mild-moderate patients, healthy controls, show that 375 are differentially expressed in the of patients. These implicated pathogenesis targets for candidate drugs prevent or treat complications. Based proteomics clinical lab tests, also report 12-plasma protein signature model...

10.1038/s41467-022-28639-4 article EN cc-by Nature Communications 2022-02-17

Background While the cardiovascular risk of hyperglycemia has been thoroughly elucidated in patients with type 2 diabetes (T2DM) hospitalized for myocardial infarction, evidence surrounding acute severe is less well-established. Our study aimed to explore impact diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS), both conditions, on outcomes T2D admitted ST-elevation infarction (STEMI). Methods We used National Readmission Database (2016–2019) extract T2DM STEMI at...

10.1371/journal.pone.0318774 article EN cc-by PLoS ONE 2025-02-06

To identify the characteristics, management and hospital outcomes of acute coronary syndrome (ACS) patients in Gulf region Middle East.Overall, 8176 consecutive with final diagnosis ACS were recruited 6 months, from 64 hospitals countries. The mean age was 56 years. At presentation, 40% had diabetes 38% current smokers. Of 2268 eligible for reperfusion, 183 (8%) underwent primary percutaneous intervention, 1856 (82%) received thrombolytic therapy 219 (10%) did not receive any reperfusion....

10.2143/ac.64.4.2041607 article EN Acta Cardiologica 2009-08-20

The authors explored the prevalence and impact of cardiovascular risk factors (CVRFs) in patients presenting with acute coronary syndrome (ACS). During a five-month period 2007, six adjacent Middle Eastern countries participated Gulf Registry events. CVRFs were identified on admission. Patients' characteristics in-hospital outcomes analyzed across types ACS. Among 6704 consecutive ACS, 61% had non–ST elevation ACS (NSTEACS) 39% ST–elevation myocardial infarction (STEMI). Female sex, old age,...

10.1002/clc.20873 article EN Clinical Cardiology 2011-01-01

Limited data are available on patients with acute coronary syndromes (ACS) and their long-term outcomes in the Arabian Gulf countries. We evaluated clinical features, management, in-hospital, of such a population.A 9-month prospective, multicenter study conducted 65 hospitals from 6 countries that also included 30 day 1-year mortality follow-up.ACS those ST-elevation myocardial infarction (STEMI) non-ST-elevation syndrome (NSTEACS), including non-STEMI unstable angina. The registry collected...

10.5144/0256-4947.2012.9 article EN cc-by-nc-nd Annals of Saudi Medicine 2012-01-01

Background Inflammation is an independent causal risk factor for atherosclerotic cardiovascular diseases ( ASCVDs ). However, whether hs CRP (high‐sensitivity C‐reactive protein) prognostic across various levels of atherogenic lipid measures such as low‐density lipoprotein cholesterol, non–high‐density apolipoprotein B and total cholesterol/high‐density cholesterol in primary prevention unknown. Methods Results We studied 9748 ARIC (Atherosclerosis Risk Communities) study participants who...

10.1161/jaha.119.013600 article EN cc-by-nc-nd Journal of the American Heart Association 2020-01-30
Coming Soon ...